Исследование рака – Unigent

Сортировка по:

стр.:

Fas C-Terminal Tripeptide,≥98%, 25mg

-

Fas C-Terminal Tripeptide,≥98%, 25mg

CT1-3,98%, 5mg

-

CT1-3,98%, 5mg

CT1-3,98%, 10mg

-

CT1-3,98%, 10mg

CT1-3,98%, 25mg

-

CT1-3,98%, 25mg

Panobinostat lactate,98%, 5mg

-

Panobinostat lactate,98%, 5mg

Panobinostat lactate,98%, 25mg

-

Panobinostat lactate,98%, 25mg

(-)-Irofulven,≥98%, 5mg

-

(-)-Irofulven,≥98%, 5mg

DRF-1042 ,≥98%, 5mg

-

DRF-1042 ,≥98%, 5mg

Macropa-NH2 hydrochloride,≥98%, 5mg

-

Macropa-NH2 hydrochloride,≥98%, 5mg

LHC-165,≥98%, 1mg

-

LHC-165,≥98%, 1mg

diABZI STING agonist-1 Tautomerism,≥99%, 5mg

-

diABZI STING agonist-1 Tautomerism,≥99%, 5mg

Nogalamycin ,≥95%, 1mg

-

Nogalamycin ,≥95%, 1mg

стр.: